ARMI | BioFabUSA is pleased to announce that its Chief Technology Officer Dr. Thomas Bollenbach will be speaking at the 11th annual Business of Regenerative Medicine: Innovation, Clinical Translation and Entrepreneurship Symposium. This two-day event, which is preceded by an evening reception and tour, will include lectures delivered by entrepreneurs, industry and scientific leaders like Bollenbach, panel discussions, networking events, and more.
The Symposium will take place July 17-18, 2018 at the Smilow Center for Translational Research, Perelman School of Medicine at the University of Pennsylvania. It is hosted by the Center for Cellular Immunotherapies and the Institute for Regenerative Medicine at the University of Pennsylvania in partnership with Case Western Reserve University, the Harvard Stem Cell Institute, the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech, and the Center for Commercialization of Regenerative Medicine.
Registration is now open, and if you act now, you will be able to take advantage of Early Registration! Click here to learn more about the event.